Apple, Palantir, Marvell Technology, Oracle and Aehr Test Systems: Why These 5 Stocks Are on Investors' Radars Today
Apple (AAPL) closed down 1.83% at $338.32, reporting Q4 revenue of $114.48B, up 12% YoY, and EPS of $2.10. Palantir (PLTR) fell 3.13% to $178.34, with Q3 revenue up 96% YoY. Marvell (MRVL) plunged 12.72% to $171.41 after announcing a $115B acquisition. Oracle (ORCL) dropped 8.76% to $119.22. Aehr (AEHR) fell 6.23% to $51.47, reporting Q1 revenue up 200% YoY.
How this was made
The 30-second read
Why it matters
Earnings beats across Apple, Palantir, and Aehr are offset by immediate price drops, indicating profit‑taking and valuation concerns. Marvell's massive acquisition and Oracle's bond issuance dominate sector sentiment.
Market read
The article delivers fresh earnings and M&A data that directly affect five US‑listed tech stocks, offering actionable insights for short‑term traders.
What to watch
Potential regulatory scrutiny on the Marvell‑Lumentum deal and bond market conditions for Oracle.
Background
Midterm election uncertainty and AI hype frame the market backdrop for the day's earnings and deal announcements.
Ticker impact
Apple reported Q4 revenue of $114.48B (+12% YoY) and EPS $2.10 beating estimates, with after‑hours price decline.
likely short‑term pressure as investors digest the beat and high valuation.
Strong top‑line but immediate price drop suggests market skepticism despite beat.
Palantir posted Q3 revenue $2.31B (+96% YoY) and adjusted EPS $0.44 beating estimates, raising full‑year 2026 revenue outlook.
potential rebound if guidance holds, but near‑term downside pressure.
Guidance lift is positive, yet price already declined on after‑hours sell‑off.
Marvell announced agreement to acquire Lumentum in a $115B deal, with revised per‑share value and $1B synergies expected.
likely continued pressure until deal economics are clarified.
Deal size is massive; market doubts about price and integration drive sell‑off.
Oracle began marketing $10B of U.S. investment‑grade bonds, following a plan for $20B additional capital raises.
downward pressure as investors assess dilution risk.
Equity impact from large bond issuance outweighs any financing benefit.
Aehr reported record Q1 2027 revenue $33.01M (+200% YoY) and EPS $0.28 beating estimates, with strong backlog.
short‑term upside as investors reward rapid growth.
Small‑cap with strong beat and backlog may attract speculative buying.
Market effects
Tech earnings and a mega‑M&A reshape semiconductor and AI testing outlooks.
U.S. market sees mixed reactions across large‑cap and small‑cap tech stocks.
Marvell-Lumentum deal is one of the largest semiconductor transactions globally.
Counterpoint
Despite earnings beats, price declines suggest over‑optimism; contrarians may short on valuation concerns.
Key entities
- companyApple Inc.
Technology hardware and services giant.
- companyPalantir Technologies Inc.
Data analytics software provider.
- companyMarvell Technology Inc.
Semiconductor designer.
- companyOracle Corporation
Enterprise software and cloud services.
- companyAehr Test Systems Inc.
AI semiconductor testing equipment maker.
